Bioinformatics analysis basing on public TCGA databases indicates that BCAR4 was highly expressed in ESCC tissues and closely correlated with poor prognosis of ESCC patients, suggesting that BCAR4 may serve as an oncogene to promote ESCC malignant progression. This evidence concerns the gene BCAR4 and esophageal squamous cell carcinoma.